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Introduction
An aorta-atrial fistula (AAF) is a rare but complex 
pathological condition that can either be congenital or 
acquired. Usually AAF is secondary to another pathological 
condition. An AAF is characterised by the presence of the 
abnormal intra cardiac flow between the aorta and the 
left or right atrium. The underlying disease needs to be 
understood thoroughly to enable planning the optimal 
therapeutic strategy.  Here we present a comprehensive 
overview of the clinical characteristics, subtypes of AAF, 
the role of the imaging modalities as well as different 
therapeutic options to treat AAF. It is hoped that this 
overview will help clinicians in identifying AAF as well as 
providing optimal treatment.
Clinical presentation
AAF can affect patients from a broad age range, and 
has been described in patients ranging from 5 days old 
to 85 years old (1,2). The clinical presentation of AAF 
encompasses a wide range of signs and symptoms of heart 
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failure including dyspnoea, chest pain, palpitations, fatigue, 
weakness coughing or oedema. 
As the AAF redirects oxygen rich blood from the aorta 
through the fistula back into one of the cardiac chambers, 
the mechanism of heart failure is thought to be due to 
volume overload and cardiac remodelling. Furthermore, 
and most likely related to the shunt volume, the AAF can 
also result into distension of the atrial wall, with or without 
subsequent occurrence of atrial fibrillation. If blood is 
redirected directly into the ventricles, extra volume can 
cause increased ventricular strain and lead to cellular 
remodelling. Continuous right-sided volume overload 
would eventually lead to an increase in pulmonary pressure, 
pulmonary oedema and ultimately the development of 
right ventricular failure. Physical examination may reveal 
a continuous murmur at the right upper sternal border. 
A murmur is, however, a non-specific sign and is not 
indicative of the severity of the AAF. Despite this, when a 
new continuous cardiac murmur is detected in patients with 
a history of cardiac surgery, an occurrence of AAF should 
be considered. This is especially true when other signs or 
symptoms of heart failure are present. Furthermore, left-
sided volume overload can cause eccentric left ventricular 
hypertrophy and mitral annular dilation with secondary 
mitral insufficiency. This will result in a worsening of heart 
failure symptoms and may alter treatment options. 
Types of AAF
There are a number of manners in which AAF can evolve, 
and the anatomy of these different configurations are shown 
in Figure 1.
Congenital AAF 
Reports of congenital AAF are less common compared 
to acquired AAF. Congenital AAF can be subdivided into 
two major sub-groups, congenital aorto-atrial tunnels 
and coronary cameral fistulas. Aorto-atrial tunnels are 
congenital anomalies originating above the sinotubular 
ridge, caused by an inherited weakness in the aortic wall, 
leading to the formation of a tunnel into one of the atria (3). 
Coronary cameral fistulas occur when one of the coronary 
arteries forms a shunt directly into the atria (3-5). Another 
very rare anomaly is the idiopathic aortic root (sinus of 
Valsalva) atrial fistula which was recently described by 
Campisi et al. (6). Clinical presentation of congenital AAF 
can range from asymptomatic to severe heart failure. Early 
correction of these anomalies is therefore recommended 
due to the fact that the symptoms are likely to worsen over 
time, with a subsequent higher surgical risk when patients 
become symptomatic (3,7-9).
Acquired AAF
Acquired AAF is associated with a wide range of conditions 
as shown in Table 1. Endocarditis is one of the most 
important contributory causes of AAF. The inflammatory 
processes involved in this disease, together with bacterial 
destruction of tissue, can weaken the integrity of the 
aortic and atrial walls and hence increase vulnerability to 
fistula formation. The incidence of AAF in the setting of 
endocarditis ranges from 1.6% in patients with native valves 
up to 5.8% in patients with a prosthetic valve (10). Often a 
paravalvular abscess coincides with an endocarditis infected 
Figure 1 Anatomy of aorto-atrial fistulas.
Table 1 Conditions associated with acquired aorta-atrial fistulas (AAF)
Endocarditis
Previous cardiac surgery
Aorta dissection/aneurysms
Ruptured sinus of Valsalva aneurysm
Iatrogenic (suture or perforation associated)
Vasculitis (Behcet’s disease, giant cell arthritis)
Trauma
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aortic root. This can be detected on transesophageal 
echocardiography (TEE), in the mid-esophageal long 
axis view (Figure 2). These abscesses can destroy cardiac 
tissue and protrude into a cardiac cavity. In the majority of 
infective endocarditis cases, the fistulous communication is 
between the aorta and the adjacent left atrium (11,12).
Certain common cardiac surgical procedures can also 
be associated with AAF formation without endocarditis 
(Table 2). In cases where infection is not present, fistulas 
are generally more common between the aorta and the 
right atrium than aorto-left atrial fistulas. Fistula formation 
between the left atrium and aorta is very rare due to the 
anatomical position of these structures. The occurrence of 
AAF in aortic surgery is much more common compared 
to coronary artery bypass grafting (CABG) surgery. It is 
thought that suture-related causes, as well as the location 
of the suture area, are detrimental factors related to the risk 
of AAF formation. In patients without a history of cardiac 
surgery or infection, ruptured sinus valsalva aneurysm, 
aortic dissections or aneurysms are the major cause of AAF 
formation. 
Special consideration should also go to patients who 
have undergone percutaneous closure of atrial septal defects 
using an occluding device. Erosion through the atrial wall 
due to the oversizing of the occlude device or a deficient 
aortic rim can result in fistula formation. It has previously 
been assumed that motion of the cardiac wall in conjunction 
with the closing tension of the device may cause the edge 
of the disk to erode into the aortic wall (13). Therefore, 
long-term follow-up of these patients is essential, especially 
when large devices have been implanted. It has also been 
recommended to avoid the use of closure devices in patients 
with an aortic rim of less than 5 mm (14).
Systemic diseases associated with vasculitis such as 
Behcet’s disease or Kawasaki have a higher overall incidence 
of developing vascular fistula (15,16). For example, we 
identified two cases of AAF in patients with vasculitis, 
one patient with Behcet’s disease with no other cardiac 
anomalies and finally a patient with giant cell arteritis, who 
had undergone a repair of an aortic dissection (17,18). 
Although connective tissue diseases (e.g., Marfan) have 
a higher incidence of developing vascular abnormalities 
such as aortic aneurysms, to our knowledge, no reports on 
AAF are currently available in this patient category. Other 
incidental causes of acquired AAF reported in literature 
include chest trauma and placements of extra-cardiac stents 
with subsequent migration of these stents (19-21).
Imaging techniques to diagnose AAF
Echocardiography
Both TEE and trans-thoracic echocardiography (TTE) 
can be used to evaluate AAF. Colour Doppler TEE often 
provides superior image quality in cases where fistulas 
occur from the posterior aspect of the aorta due to the 
more optimal alignment of the probe. TTE, on the other 
hand, renders a better orientation of the atria compared to 
TEE. 3D-TEE might become the future method of choice 
Figure 2 Aortic root abscess as seen on transesophageal echocardiography, (A) mid-esophageal aortic short axis view and (B) mid-esophageal 
aortic long axis view, show multiple abscess chambers (arrows) in the aortic root.
Table 2 Cardiac surgical procedures associated with aorta-atrial 
fistulas (AAF) formation
Aorta (root) surgery
Valve surgery (especially of the aortic valve)
Coronary artery bypass graft surgery
Percutaneous closure of atrial septal defects (ASD)
Abcess
Aortic valve
A B
Abcess
Aortic valve
Right ventricle
Right 
atrium
Left 
ventricle
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for the assessment of AAF because 3D imaging allows 
spatial orientation and high anatomic definition of adjacent 
structures (11,22,23).
A major benefit of echocardiography is the possibility to 
examine cardiac defects in the operating room at all stages 
of surgery (before, during and after). Possible drawbacks 
include the requirement of high-frequency transducers with 
high spatial resolution in certain type of patients, limitations 
in evaluation of vascular structures positioned outside 
the heart and sometimes TEE probe insertion is contra-
indicated.
Cardiac magnetic resonance imaging (CMR) and cardiac 
catheterization
CMR has proven to be superior in the quantification 
of cardiac shunt fraction and flow measurements when 
compared to echocardiography and computed tomography 
(CT) alone (24). Sensitivity of CMR to detect aortic 
vascular anomalies is comparable to angiocardiography. 
However, with regard to pulmonary artery flow, CMR 
is the only available technique that allows quantitative 
flow measurements and is considered the gold standard 
for assessment of pulmonary vein anomalies (24,25). 
In cases of intra-cardiac shunts, CMR can be used for 
anatomical detection and calculation of shunt fraction 
(26,27). Drawbacks of CMR are its inability to be used 
intraoperatively and the use of gadolinium-based dye 
as a contrast medium, which has been associated with 
nephrogenic systemic fibrosis.
Cardiac catheterization can also be used to accurately 
assess shunt quantification, but flow measurements are less 
accurate compared to CMR (24). The drawback of cardiac 
catheterization is mainly its invasive nature, which has its 
inherent risks and potential problems.
Therapy of AAF
Once an AAF is diagnosed, the underlying disease 
needs to be understood thoroughly to plan the optimal 
therapeutic strategy.  Due to the low incidence of AAF, 
no clinical trials have been performed in these patients 
and treatment strategies are based on expert opinion and 
consensus amongst the treating physicians. Correction of 
an AAF is strongly recommended when the AAF is not 
trivial. Uncorrected AAF may continue to impose a risk of 
progression to overt heart failure. The repair of an AAF 
can either be surgical or percutaneous. Surgical closure of 
an AAF is usually based on patches or ligation of the fistula 
tract and percutaneous closure can be achieved by using 
an occluder device, coil embolization or covered stents. In 
the case of percutaneous closure with an occluder device, 
an Amplatz Ductal Occluder device is most commonly 
used (28). In all patients who undergo percutaneous closure 
with an Amplatzer device follow-up through postop 
imaging is necessary to detect if there is a residual fistula 
or pseudoaneurysm present (29). Given that the majority 
of information regarding AAF is from case reports, it is 
difficult to accurately gauge the treatments success rates 
or mortality rates. However, a recent review of these case 
reports from our own group indicated that the overall 
treatment success rate for both surgical and percutaneous 
closure is above 80%. The mortality rate for both surgical 
and percutaneous closure using the same data set was 
around 7% (30).
Small asymptomatic aorto-atrial fistulas can sometimes 
be managed pharmacologically, by reduction of cardiac 
afterload and the use of diuretics. Conservative management 
should involve close monitoring of the patient and if clinical 
conditions deteriorates, active closure of the fistula should 
be reconsidered. Clinicians should always keep in mind 
that even asymptomatic and small AAF have a tendency 
to worsen over time, with subsequent higher surgical risk 
when patients become symptomatic. 
Conclusions
AAF is a relatively rare but very serious condition. 
Clinicians should consider the possibility of AAF, when 
a new continuous cardiac murmur occurs, especially in 
patients with a history of cardiac surgery or with signs of 
heart failure. Pre-operative localisation and quantification 
of intra-cardiac shunts can best be studied using CMR, 
whereas echocardiography is ideal to provide perioperative 
assessment and guidance for the surgeon. In the absence 
of clinical trials, clinical approach in treating AAF is based 
on expert opinion and consensus. Closure of the AAF 
fistula tract is generally recommended, even if the fistula 
is asymptomatic, based on observations that AAF have a 
tendency to worsen over time. Further studies would be 
required to define optimal therapeutic strategies, but these 
are hindered by the rarity of the occurrence of this disorder.
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